ClinicalTrials.govpublic full text
Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection
hepatitis c, chronic, hiv infection, hiv/hcv co-infection, antiretroviral therapy, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1032767
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.